2 hours William Blair Initiates Coverage on Apellis Pharmaceuticals (NASDAQ:APLS)MarketBeat
William Blair began coverage on Apellis Pharmaceuticals in a research note on Wednesday. They set an “outperform” rating on the stock.
Nasdaq 100 · Pharmaceuticals · Science
X